Western Health Advantage
Tabrecta (capmatinib)
Drugs for Cancer : Drugs for Cancer
  • Prior Authorization: Multiple Sclerosis (MS):
    Documented Diagnosis: Yes
    Duration: 2 Month(s)
    Reauthorization Required: Yes

    Secondary Progressive Multiple Sclerosis:
    Documented Diagnosis: Yes
    Reauthorization Required: Yes

  • Prior Authorization: Growth Hormone Deficiency:
    Documented Diagnosis: Yes
    Duration: 1 year(s)
    Reauthorization Required: Yes

  • ST_APPLIES
  • Quantity Limit: limit maximum 1 EA PER 1 day(s)